Symptom monitoring: Fatigue, numbness or cognitive problems should improve with treatment
Children's requirements are lower and increase with age: infants aged 0-6 months have a safe intake of about 0.3 g daily, those aged 712 months need 0.4 g daily, children aged 13 years require 0.5 g, those aged 46 years need 0.8 g, and children aged 710 years should receive 1.0 g daily
Dosage tiers from clinical trials The Phase 2 dose-ranging work examined several dosage levels
It also features co-factors, such as Alpha Lipoic Acid, L-Cysteine, Riboflavin-5-Phosphate, L-selenomethionine, and Chelated Molybdenum to support bioavailability and the production and effectiveness of Glutathione
Cheng, Jin-Pei
The Online Journal of Science and Technology-July , 10 (3)